Navigation Links
Adeona's Planned Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease is Hot Topic at 2011 California ALS Research Summit
Date:9/30/2011

ANN ARBOR, Mich., Sept. 30, 2011 /PRNewswire/ -- Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN), a developer of innovative medicines for serious central nervous system diseases, announced today that its planned clinical trial of the Company's proprietary zinc-based therapy for patients suffering from amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's Disease, will be featured during the Hot Topics session at the 2011 California ALS Research Summit (ALS Summit) on Saturday, October 1, 2011. Todd D. Levine, M.D., President of PNA Center for Neurological Research (PNA), Assistant Clinical Professor at the University of Arizona, Co-Director of the Banner Samaritan ALS Center in Phoenix, Arizona and Lead Principal Investigator of the planned clinical trial will present the potential benefits of zinc therapy for ALS patients. Dr. Levine will also discuss preliminary data from PNA's ongoing Phase I/II open label safety study of zinc therapy in ALS patients at the ALS Summit.

"I am very excited to present our theories on the potential role of zinc in the treatment of ALS. We believe that by giving high doses of zinc to ALS patients, we can decrease the amount of toxicity from unbound glutamate and prevent neurotoxicity," said Dr. Levine. "Our goal is to improve the quality of life of patients with ALS by slowing the progression of this devastating disease."

About Amyotrophic Lateral Sclerosis (ALS)

ALS is a devastating progressive neurodegenerative disease that affects the nerve cells in the brain and the spinal cord in people of all ages and both sexes. It is estimated that as many as 30,000 Americans may have the disease at any given time. The progressive degeneration of the motor neurons in ALS eventually leads to the death of the patient. Motor neurons reach from the brain to the spinal cord and from the spinal cord to the muscles throughout the bo
'/>"/>

SOURCE Adeona Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Plavix(R) Indications Expanded in Japan to Include Patients with Acute Coronary Syndrome for Whom Percutaneous Coronary Intervention Is Being Planned
2. TargeGen Announces Planned Initiation of Clinical Trial of JAK2 Inhibitor TG101348 in Myeloproliferative Disease Patients, and Presentations at ASH
3. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
4. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
5. Celtic Pharma Announces Update on Status of XERECEPT(R) Program Sale Planned in 2009
6. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
7. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
8. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
9. Xanodyne Announces Planned President & CEO Succession
10. Breast Cancer Patient First in Latin America to Receive Treatment Using Elekta VMAT Planned with Monaco Software
11. Phase 3 Trial of Aflibercept in Second-Line Metastatic Colorectal Cancer to Continue as Planned at Recommendation of Independent Data Monitoring Committee
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 2015 Research and ... of the  "2015 Strategies in the Global ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , ... of the orthopedics market, including forecasts for ... categories. , ,In addition, the report presents ...
(Date:5/27/2015)... Research and Markets ( ... the  "North America Mammography Market - Growth, ...  report to their offering.      ... detailed type of imaging that customs a ... mammography exam, called a mammogram, is used ...
(Date:5/27/2015)... 27, 2015 OpportunityAnalyzer: Sepsis - Opportunity Analysis ... suffer from a series of diverse complications arising from ... blood or tissues, which cause a rapidly progressing hyperactive ... rates near 50% depending on disease severity. The syndrome ... of the global marketplace, which for the purposes of ...
Breaking Medicine Technology:Global Orthopedics Market Strategies 2015 2North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 2OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 3OpportunityAnalyzer: Sepsis - Opportunity Analysis and Forecasts to 2021 4
... 2012   CANTEL MEDICAL CORP. (NYSE:CMN) announced today ... presenting at the Needham & Company, LLC  14th Annual ... AM ET on Wednesday, January 11, 2012 at The ... session immediately following the presentation. In addition, Mr. Krakauer ...
... 4, 2012 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), ... focused on cardiac and vascular surgery, announced today that ... position of Vice President, Research and Development; and David ... President, Market Development Surgical Adhesives and Starch Medical Relations.  ...
Cached Medicine Technology:CryoLife Enhances Management Team with Promotions 2CryoLife Enhances Management Team with Promotions 3CryoLife Enhances Management Team with Promotions 4CryoLife Enhances Management Team with Promotions 5
(Date:5/27/2015)... Gravity and volume loss in the skin have met ... CaSaroll, is excited to introduce a custom menu of ... without surgical intervention, and without downtime. , “We now ... procedure that can lift skin using focused ultrasound, and ... more lifting formula than its predecessor Radiesse, to visibly ...
(Date:5/27/2015)... Throughout the past few months, Push to Walk has ... and reliability of the Shaw Gait Assessment in comparison to ... in the Department of Physical Therapy at Seton Hall University ... Gait Assessment is a free online tool, where the GaitRite ... considered the gold standard in providing information about how someone ...
(Date:5/27/2015)... Cincinnati Veterans Affairs Medical Center invites caregivers and ... noon-2p.m. in the auditorium. This event provides an ... assistance to Veterans in their homes. , ... by the medical center staff. In order to ... the caregiver must provide monthly care including room and ...
(Date:5/27/2015)... May 28, 2015 Calls Upon Individuals, Organizations ... A new nationwide initiative – a “Summer of Service” – ... and build partnerships to grow the number of individuals and ... its commitment to Veterans by inviting the community to visit ... June 29, 2015 from 1 – 3:00 p.m. in the ...
(Date:5/27/2015)... May 28, 2015 Thermage was the first ... Aesthetics was founded in 2007 coinciding with the release of ... In fact, Precision Aesthetics was the first practice in ... The new platform produced results that had never been achieved ... inception, Thermage is still considered by many as the leading ...
Breaking Medicine News(10 mins):Health News:Skin Expert Holly CaSaroll Announces New Cutting Edge Results with RadiessePlus Filler Available at Detroit Skin and Wellness Clinic 2Health News:Push to Walk Partners with Seton Hall University for Study 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 2Health News:VA Begins “Summer of Service” to Bolster Volunteer Assistance for Veterans 3Health News:Non-Surgical Fat Reduction and Skin Tightening Procedures, Thermage and Exilis, Increase 200% at Precision Aesthetics in New York, April 2015 2
... of patients with hepatic granulomas have found sarcoidosis and ... granulomas, recent works have noted some patients with chronic ... associations. Today, patients that undergo liver biopsy often have ... possible anti viral therapy. The age of HIV and ...
... used for the relief of fever, headaches, and other ... NSAIDs are well documented and acetaminophen is accepted to ... effects of short-term, especially high-dose NSAID and acetaminophen use ... to be published on November 21 , 2008 in ...
... Dec. 29 Stereotaxis, Inc.,(Nasdaq: STXS ) ... and existing institutional investors to raise gross proceeds of ... in two separate,concurrent transactions. A portion of the warrants ... full, these warrants would provide an additional,approximately $10 million ...
... long-term complications of blood sugar disease, scientists say ... who have gastric bypass surgery not only lose weight ... study finds. , Also called bariatric surgery, the procedure ... thereby reducing the amount of food one can eat. ...
... day in the United States,approximately 10,000 babies are born. On ... across the country welcome their babies,into the world by offering ... Year.,Parents of 2009 New Year,s babies can go to ... Year,s Baby coupons for free Beech-Nut,foods. , ...
... Internet - , , ANTHEM, Ariz., Dec. 29 ... of its new web site at http://www.mychoicedentist.com and ... Phoenix , Arizona, area is proceeding successfully. "Arizona is ... CEO. "We anticipate expanding this service to almost every major ...
Cached Medicine News:Health News:May hepatic granulomas be part of the histological spectrum of chronic hepatitis C? 2Health News:Acute gastric injury due to high-dose analgesics? 2Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 2Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 3Health News:Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants 4Health News:Gastric Bypass Halts Diabetes in Obese Teens 2Health News:Gastric Bypass Halts Diabetes in Obese Teens 3Health News:Beech-Nut Offers Free Food for Babies Born on January 1, 2009 2Health News:Beech-Nut Offers Free Food for Babies Born on January 1, 2009 3Health News:Prime Companies Announces Launch of New Dental Web Site 2
For the qualitative detection of Hepatitis B surface Antigen (HBsAG) in human serum, plasma and whole blood specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the qualitative detection of luteinising Hormone (LH) in urine specimens...
For the qualitative detection of group A Streptococcal antigen from throat swabs...
Medicine Products: